POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GKZ_A_B40A500_1 (ANTI-METHAMPHETAMINE SINGLE CHAIN FV)	3go1	FAB 268-D, HEAVY CHAIN FAB 268-D, LIGHT CHAIN (Homo sapiens)	5 / 11	TYR H  33 TYR H  47 TYR H  50 TYR L  34 TYR L  36	None	0.83A	39.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GKZ_A_B40A500_1 (ANTI-METHAMPHETAMINE SINGLE CHAIN FV)	4jy4	PGT121 HEAVY CHAIN PGT121 LIGHT CHAIN (Homo sapiens)	5 / 11	TYR B  33 SER B  35 TYR B  50 TYR A  36 HIS A  89	None	1.14A	35.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GKZ_A_B40A500_1 (ANTI-METHAMPHETAMINE SINGLE CHAIN FV)	4jy6	PGT123 HEAVY CHAIN PGT123 LIGHT CHAIN (Homo sapiens)	5 / 11	TYR B  33 SER B  35 TYR B  50 TYR A  36 HIS A  89	None	1.16A	33.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GQP_H_B40H1201_1 (ANTI-METH SCFV)	1mm3	MI2-BETA(CHROMODOMAI N HELICASE-DNA-BINDING PROTEIN 4) AND TRANSCRIPTION FACTOR WSTF (Homo sapiens)	5 / 11	SER A  30 TYR A  31 PHE A  11 GLU A  10 HIS A   8	None	1.48A	10.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4GQP_H_B40H1201_1 (ANTI-METH SCFV)	3go1	FAB 268-D, HEAVY CHAIN FAB 268-D, LIGHT CHAIN (Homo sapiens)	5 / 11	TYR H  33 TYR H  47 TYR H  50 TYR L  34 TYR L  36	None	0.83A	39.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4GQP_H_B40H1201_1 (ANTI-METH SCFV)	4jy6	PGT123 HEAVY CHAIN PGT123 LIGHT CHAIN (Homo sapiens)	5 / 11	TYR B  33 SER B  35 TYR B  50 TYR A  36 HIS A  89	None	1.18A	35.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP6_A_B40A601_1 (TRANSPORTER)	1ck7	PROTEIN (GELATINASE A) (Homo sapiens)	4 / 5	ASP A 564 VAL A 568 ASP A 569 GLY A 585	None	1.18A	21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP6_A_B40A601_1 (TRANSPORTER)	1tuz	DIACYLGLYCEROL KINASE ALPHA (Homo sapiens)	4 / 5	ASP A  98 VAL A  93 ASP A  92 GLY A  81	None	1.18A	11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP6_A_B40A601_1 (TRANSPORTER)	4h1s	5'-NUCLEOTIDASE (Homo sapiens)	4 / 5	ASP A 121 ASP A 524 PHE A 500 GLY A 419	None	1.21A	22.41